Back to Search Start Over

ADC Therapeutics Provides Business Updates

Source :
GlobeNewswire. January 4, 2024
Publication Year :
2024

Abstract

ZYNLONTA[sup.(R)] [sup. 1 ] 4Q 2023 net sales expected to be ~$16.5 million, a double-digit percentage increase as compared to 3Q 2023 LOTIS-7: Study of ZYNLONTA in combination with bispecifics [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.778198545